Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › HORIZON

Triple-A-COAT · Sustainable Development of a Safe and Biobased Antimicrobial, Antifungal and Antiviral Nanocoating Platform

HORIZONStatus: SIGNED1 September 202231 August 2026EU funding €3,731,633Call HORIZON-CL4-2021-RESILIENCE-01

Human pathogens can persist on textiles and high-traffic surfaces for hours, days or even longer when protected in biofilms, increasing risk of infection spreading. Conventional cleaning has no lasting effect as contamination can re-occur almost immediately. Available antimicrobial coatings are based mainly on the release of silver ions and other biocides that present risks for resistance development and environmental damage. Inorganic nanoparticles are also a concern for human health. Nanocellulose is a versatile nanomaterial obtained from wood pulp or biotechnological methods, which has excellent physical properties for coatings, enabling controllable and standardised application of antimicrobial functionalities. In Triple-A-COAT the 3 forms of nanocellulose will be augmented for antimicrobial/antiviral activity through grafting/adsorption of novel, resistance-proof compounds with excellent activities against bacteria, fungi and/or viruses, and nanopatterning to create bio-inspired antimicrobial surfaces. Spray coating and thin film applications will be developed, optimising adherence to plastic, metal, textiles and glass. The most effective coatings will be evaluated for antimicrobial/antiviral activity, durability and non-toxicity using ISO standard tests, and in a simulation of a bus environment over 6 months to reach TRL6. A life cycle assessment of the platform will also be completed.The project consortium involves companies, academic and SME partners with leading expertise in novel antimicrobial and antiviral technology, nanocellulose production and functionalisation, coatings development and characterisation, as well as a bus manufacturer and an external User Committee. Within 5-10 years after the end of the project, the results will be commercialized for impact in the transportation and healthcare sectors, contributing to the better control of infectious disease, and boosting the competitiveness and research leadership of EU industry including SMEs.

Consortium · 15 organisations

coordinator

KATHOLIEKE UNIVERSITEIT LEUVEN

BE · €1,988,108

participant

IVECO BELGIUM

BE · €41,250

associatedPartner

SuSoS AG

CH

participant

SIRRIS HET COLLECTIEF CENTRUM VAN DE TECHNOLOGISCHE INDUSTRIE

BE · €399,816

associatedPartner

ENGEDI SCIENCE LTD

UK

associatedPartner

IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE

UK

participant

ACADEMISCH ZIEKENHUIS GRONINGEN

NL · €143,913

participant

CELLUGY

DK · €235,932

associatedPartner

VIROLOGY RESEARCH SERVICES LIMITED

UK

participant

SAPPI NETHERLANDS SERVICES BV

NL · €111,875

participant

MELODEA LTD

IL · €512,500

participant

EDUCELL PODJETJE ZA CELICNO BIOLOGI JO DOO

SI

participant

STELLENBOSCH UNIVERSITY

ZA · €146,240

participant

2.-0 LCA CONSULTANTS APS

DK · €152,000

participant

VAN HOOL N.V.

BE

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.